Christopher Carite

Christophe is a French citizen graduated in industrial pharmacy (PharmD), Microbiology and Business Administration. He has started his industrial career as plant manager for Lallemand Bacteria Division early ninety, then occupied various positions in R&D and Marketing in B2B of Pharmaceuticals Ingredients. He has joined 4D pharma at the early beginning of the company in 2014 and he has assumed the challenge to produce  freeze dried strict anaerobic bacteria at the industrial scale level ( 3500 L fermentor, 5 to 20m2 Freeze dryer) to deliver high concentrated LBPs  to patients (> 1010 CFU/caps, shelf life up to 2 years) recognised by several patent families granted. In addition, Christophe has integrated “in house” all 4D pharma Manufacturing and Controls under inspected cGMP.

Right now, he assume the position of Process development/CMC Director and member of 4D Pharma Executive team reporting directly to the CEO.

Céline Durant

Adam Baker

Robert Silvers

Lukas Van Oudenhove

Lukas graduated as a Medical Doctor at KU Leuven in 2001. During his specialist training in psychiatry, he was granted a PhD-fellowship of the Research Foundation – Flanders, resulting in his doctoral thesis ‘Psychobiological mechanisms in functional dyspepsia. Converging evidence from psychophysiology & functional brain imaging?’ (KU Leuven, 2008). He then worked as a postdoctoral fellow of the Research Foundation – Flanders at the Translational Research Center for Gastrointestinal Diseases (TARGID) of KU Leuven from 2009 until 2012. In 2012, he was appointed assistant research professor of the KU Leuven Special Research Fund, allowing him to establish his own group, the Laboratory for Brain-Gut Axis Studies (LaBGAS). His research has been internationally authoritative, as reflected by more than 200 peer-reviewed publications, numerous invited and abstract presentations at scientific meetings, and several international research awards. In 2020, Lukas got granted an ERC Consolidator Grant MoodBugs, focus on microbiota-gut-brain signaling mechanisms mediating the impact of the gut microbiota on stress and fear responses in humans.

Boushra Dalile

Boushra Dalile is a senior PhD researcher. She graduated with a BA in Psychology from Swinburne University of Technology, Australia, an MS.c. in Cognitive Neuroscience from the University of Skövde, Sweden, and will soon graduate with a PhD in Biomedical Sciences from the KU Leuven in Belgium. She conducts interdisciplinary research investigating the influence of nutrition-related interventions on sensitivity to psychosocial stress and anxiety-related processes, with the aim of unveiling mechanisms of action.. Specifically, she focuses on the effects of dietary fiber and the role of short-chain fatty acids in the human microbiota-gut-brain axis. Her scientific work contributed to multiple conference abstracts and peer-reviewed publications.

Marcus Böhme

Dr. Marcus Böhme is a R&D Specialist working at the Nestlé Research Centre in Lausanne, Switzerland where he is leading projects on the Gut-Brain Axis. Prior to joining Nestlé, he completed his undergraduate training in Nutritional Science at the Friedrich-Schiller-University Jena, Germany, where he also received his PhD in Neuroscience. Subsequently, Dr. Böhme undertook a 4-year postdoctoral fellowship in the lab of Prof. John Cryan at the University College Cork, Ireland, where he studied the role of the gut microbiome on brain and cognitive health across the lifespan. His research focusses on how diet shapes brain health and behavior with the gut microbiota acting as a novel mediator between diet and maintenance of brain health.